Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Janus

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|December 17, 2008
[Chemotherapy and renal toxicity]Vincent Launay-Vacher, Corinne Isnard-Bagnis, Nicolas Janus, et al.
La Revue Du Praticien|April 21, 2012
[How to adjust the dose of drugs in chronic kidney disease?]Vincent Launay-Vacher, Nicolas Janus, Sarah Zimner-Rapuch, et al.
Presse Medicale (Paris, France : 1983)|July 24, 2012
[Letter on the article: "Kidney and HIV infection"]Sarah Zimner-Rapuch, Nicolas Janus, Sabine Amet, et al.
Bulletin Du Cancer|December 3, 2011
[Management of targeted therapies in hemodialysis patients]Nicolas Janus, Vincent Launay-Vacher, Gilbert Deray, et al.
Bulletin Du Cancer|December 8, 2011
[Management of analgesics in cancer patients with renal impairment]Jean-Baptiste Rey, Thao Tran, Didier Ammar, et al.
Bulletin Du Cancer|November 30, 2011
[Anticancer drugs management in renal insufficiency patients]Sarah Zimmer-Rapuch, Stéphanie Lheureux, Fabien Brocard, et al.
Urologic Oncology|November 17, 2009
Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinomaVincent Launay-Vacher, Jorge Ayllon, Nicolas Janus, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2011
Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based studyGaëlle Breton, Marc Froissart, Nicolas Janus, et al.
European Journal of Radiology|January 9, 2009
Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST studyNicolas Janus, Vincent Launay-Vacher, Svetlana Karie, et al.
AIDS Reviews|July 21, 2016
Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?Blandine Aloy, Imane Tazi, Corinne Isnard Bagnis, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|December 17, 2008
[Chemotherapy and renal toxicity]Vincent Launay-Vacher, Corinne Isnard-Bagnis, Nicolas Janus, et al.
La Revue Du Praticien|April 21, 2012
[How to adjust the dose of drugs in chronic kidney disease?]Vincent Launay-Vacher, Nicolas Janus, Sarah Zimner-Rapuch, et al.
Presse Medicale (Paris, France : 1983)|July 24, 2012
[Letter on the article: "Kidney and HIV infection"]Sarah Zimner-Rapuch, Nicolas Janus, Sabine Amet, et al.
Bulletin Du Cancer|December 3, 2011
[Management of targeted therapies in hemodialysis patients]Nicolas Janus, Vincent Launay-Vacher, Gilbert Deray, et al.
Bulletin Du Cancer|December 8, 2011
[Management of analgesics in cancer patients with renal impairment]Jean-Baptiste Rey, Thao Tran, Didier Ammar, et al.
Bulletin Du Cancer|November 30, 2011
[Anticancer drugs management in renal insufficiency patients]Sarah Zimmer-Rapuch, Stéphanie Lheureux, Fabien Brocard, et al.
Urologic Oncology|November 17, 2009
Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinomaVincent Launay-Vacher, Jorge Ayllon, Nicolas Janus, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2011
Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function--the Three-City population-based studyGaëlle Breton, Marc Froissart, Nicolas Janus, et al.
European Journal of Radiology|January 9, 2009
Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: results of the FINEST studyNicolas Janus, Vincent Launay-Vacher, Svetlana Karie, et al.
AIDS Reviews|July 21, 2016
Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?Blandine Aloy, Imane Tazi, Corinne Isnard Bagnis, et al.
Pageof 5